Back to Results

A phase II, open label, multi-center trial to determine the efficacy and safety of tisagenlecleucel re-infusion in Pediatric and Adolescent Young Adult (AYA) patients with acute lymphoblastic leukemia experiencing loss of B cell aplasia

Study category: Cancer

Is this Study for You?

Let's Get Started!


Child to Adult

Type of Study



Childrens Hospital Colorado

Principal Investigator
Amy Keating,  MD

Amy Keating, MD

Study ID

Protocol Number: 20-1441

More information available at NCT04225676


Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers